Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study on Utilization Of Cabergoline For Compliance With Risk Minimization Activities (SUCRE)

NCT01270711 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT01270711
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01270711 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study on Utilization Of Cabergoline For Compliance With Risk Minimization Activities (SUCRE)
Lead sponsor
Pfizer
Phase
Observational
Overall status
Completed
Start date
November 30, 2010
Completion date
February 28, 2013
Enrollment
22,014 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hyperprolactinemia, parkinson's disease